Gateway 2011: Hospira One 2 One - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2011: Hospira One 2 One

Your online Gateway to Hospira One 2 One in 2011

275 North Field Drive
Lake Forest, Illinois, U.S.A. 60045
Call +1-224-212-2267

Don't miss Hospira One 2 One at BIO 2011, June 27-30, Washington, D.C.

About Hospira One 2 One

Hospira is a global specialty pharmaceutical and medication delivery company dedicated to developing, manufacturing and marketing healthcare products that help improve the productivity, safety and efficacy of patient care. The company’s One 2 One business is a world leader in the custom development and manufacture of sterile injectable products packaged in vials, prefilled syringes, cartridges, flexible containers and ampules.

We offer product development and contract manufacturing services at our nine worldwide facilities. Whether your product is a small molecule or advanced biologic, our highly qualified personnel in every world-class facility ensure quality, capacity and security of supply.

Visit our Stand: 4640

We would like to invite you to meet us at stand 4640 to discuss partnering and business development opportunities. 


For more information:



blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here